11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

NIM-PRS

FDA 510(k)
FDA Class 2 ·Physical Medicine

DEVICE 8252410 NIM-NEURO 2.0 INTERFACE

FDA Adverse Event
Malfunction ·MEDTRONIC XOMED INC.·Product code IKN·February 21, 2014

APEX Revision Knee

FDA UDI
Omni Life Science, Inc.·00841690114086·PS-R Insert, Size 3 x 16mm

PrimeSight

FDA UDI
SCHÖLLY FIBEROPTIC GmbH·04250480107355·Laryngoscope 10 x 186 mm, 90°

CORDIS TRAPEASE PERMANENT VENA CAVA FILTER WITH THE VISEASE ANGIOGRAPHIC VESSEL DILATOR; MODELS 466-P306AU & 466-P306BU

FDA 510(k)
FDA Class 2 ·Cardiovascular

ULTRA N-GENEOUS HDL CHOLESTEROL REAGENT 1/REAGENT2; ULTRA N-GENEOUS HDL CHOLESTREOL CALIBRATOR

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

ENDEAVOR RESOLUTE RX

FDA Adverse Event
Malfunction ·MEDTRONIC IRELAND·Product code NIQ·March 27, 2013

HEARTMATE II LVAS

FDA Adverse Event
Death ·THORATEC CORPORATION·Product code DSQ·March 18, 2011

KNIGHTSTAR 330

FDA Adverse Event
Malfunction ·GALWAY (RC)·Product code CBK·April 3, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.

FDA Enforcement
Class II ·Terminated·Welch Allyn Protocol, Inc·January 15, 2014